Citadel Advisors’s T-Rex 2X Inverse MSTR Daily Target ETF MSTZ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.39M Buy
111,300
+400
+0.4% +$5.35K ﹤0.01% 6894
2025
Q4
$1.9M Sell
110,900
-1,400
-1% -$14.2K ﹤0.01% 6022
2025
Q3
$591K Sell
112,300
-54,700
-33% -$245K ﹤0.01% 8719
2025
Q2
$698K Sell
167,000
-69,735
-29% -$437K ﹤0.01% 7843
2025
Q1
$3.32M Buy
236,735
+81,945
+53% +$1.44M ﹤0.01% 4582
2024
Q4
$4.35M Buy
+154,790
New +$13.3M ﹤0.01% 4186

Other funds holding MSTZ

Citadel Advisors's MSTZ Position: Q1 2026 in Review

Citadel Advisors sold out of T-Rex 2X Inverse MSTR Daily Target ETF (MSTZ) in Q1 2026, closing a stake of 13,364 shares — an estimated $179K sold.

Citadel Advisors first reported a position in MSTZ in Q1 2025 and held it in 4 quarters. The position peaked at $4.38M in Q1 2025. 16 funds tracked by Wall St. Rank hold MSTZ as of Q1 2026.

  • Citadel Advisors reported no remaining T-Rex 2X Inverse MSTR Daily Target ETF position as of Q1 2026 after selling out during the quarter.
  • Citadel Advisors sold 13,364 T-Rex 2X Inverse MSTR Daily Target ETF shares in Q1 2026, an estimated $179K.
  • Citadel Advisors first reported a position in T-Rex 2X Inverse MSTR Daily Target ETF in Q1 2025 and held it in 4 quarters.
  • Citadel Advisors's T-Rex 2X Inverse MSTR Daily Target ETF position peaked at $4.38M in Q1 2025.
  • 16 funds tracked by Wall St. Rank held T-Rex 2X Inverse MSTR Daily Target ETF as of Q1 2026.

Based on Citadel Advisors's 13F filing for Q1 2026, filed 15 May 2026.